Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vadas

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Annals of the Rheumatic Diseases|November 1, 1989
Phospholipase A2 and inflammationW Pruzanski, P Vadas
Arthritis and Rheumatism|July 1, 1996
Tenidap in rheumatoid arthritis: comment on the article by Blackburn et alW Pruzanski, P Vadas
Immunology Today|May 1, 1991
Phospholipase A2--a mediator between proximal and distal effectors of inflammationW Pruzanski, P Vadas
Critical Care Medicine|July 1, 1991
Serum phospholipase A2 values and septic shockP Vadas, W Pruzanski
Mediators of Inflammation|January 1, 1994
PrefaceP Vadas, W Pruzanski
The Journal of Rheumatology|October 1, 1992
Should tetracyclines be used in arthritis?W Pruzanski, P Vadas
The Journal of Rheumatology|April 1, 1990
Phospholipase A2 in articular cartilageW Pruzanski, P Vadas
Advances in Experimental Medicine and Biology|January 1, 1990
Phospholipase A2 activation is the pivotal step in the effector pathway of inflammationP Vadas, W Pruzanski
Canadian Journal of Physiology and Pharmacology|June 1, 1983
Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shockP Vadas, J B Hay
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 15, 2011
Anaphylaxis: mechanisms and managementJ K Lee, P Vadas
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Annals of the Rheumatic Diseases|November 1, 1989
Phospholipase A2 and inflammationW Pruzanski, P Vadas
Arthritis and Rheumatism|July 1, 1996
Tenidap in rheumatoid arthritis: comment on the article by Blackburn et alW Pruzanski, P Vadas
Immunology Today|May 1, 1991
Phospholipase A2--a mediator between proximal and distal effectors of inflammationW Pruzanski, P Vadas
Critical Care Medicine|July 1, 1991
Serum phospholipase A2 values and septic shockP Vadas, W Pruzanski
Mediators of Inflammation|January 1, 1994
PrefaceP Vadas, W Pruzanski
The Journal of Rheumatology|October 1, 1992
Should tetracyclines be used in arthritis?W Pruzanski, P Vadas
The Journal of Rheumatology|April 1, 1990
Phospholipase A2 in articular cartilageW Pruzanski, P Vadas
Advances in Experimental Medicine and Biology|January 1, 1990
Phospholipase A2 activation is the pivotal step in the effector pathway of inflammationP Vadas, W Pruzanski
Canadian Journal of Physiology and Pharmacology|June 1, 1983
Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shockP Vadas, J B Hay
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 15, 2011
Anaphylaxis: mechanisms and managementJ K Lee, P Vadas
Pageof 10